-
Mashup Score: 0
Researchers sought to determine the role of certain genetic variants as biomarkers in primary central nervous system lymphoma.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Tirabrutinib has received orphan drug status from the FDA and is being studied in the phase 2 PROSPECT study for patients with primary central nervous system lymphoma.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The #FDA has granted #tirabrutinib an orphan drug designation for the treatment of patients with primary central nervous system lymphoma. #PCNSL #lymsm https://t.co/NKhTPS0FAp
-
-
Mashup Score: 1
Age-adapted induction followed by high-dose chemoimmunotherapy and autologous transplant has shown promise for treating elderly, fit patients with primary central nervous system lymphoma.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Age-adapted induction followed by high-dose chemoimmunotherapy and ASCT has shown promise for treating elderly, fit patients with primary central nervous system #lymphoma. Presented at @ASH_hematology conference #ASH22. https://t.co/EFqAdUqCJd #PCNSL #lymphsm
-
-
Mashup Score: 0
Age-adapted induction followed by high-dose chemoimmunotherapy and autologous transplant has shown promise for treating elderly, fit patients with primary central nervous system lymphoma.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Age-adapted induction followed by high-dose chemoimmunotherapy and autologous transplant has shown promise for treating elderly, fit patients with primary central nervous system lymphoma. #ASH22 #lymsm #ASCT #PCNSL https://t.co/fVkQn3Vt2t
-
-
Mashup Score: 1
General Sessions Late-Breaking Abstracts Session Research, clinical trials, adult, Clinical Research, Combination therapy, Diseases, Therapies, therapy sequence, Lymphoid Malignancies, Adverse Events, Study Population, Human Gerald Illerhaus, MD1, Andrés J.M. Ferreri, MD2, Mascha Binder, MD3*, Peter Borchmann4, Justin Hasenkamp, MD5*, Stephan Stilgenbauer, MD6,…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
In #ASH22 Late Breaking Abstracts, the IELSG43 randomised trial reaffirms the importance of autologous stem cell transplant consolidation for patients with primary CNS lymphoma (PCNSL) https://t.co/GLQi5COKDl #lymsm #PCNSL https://t.co/T8SmyNq72S
-
-
Mashup Score: 0Primary central nervous system lymphoma - 2 year(s) ago
Edited by Associate Editor Laurie Sehn, this 3-part Review Series covers rare, aggressive B-cell lymphomas. First, Olszewski et al discuss a recently-designated
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Primary #CentralNervousSystem #Lymphoma👇 https://t.co/LN9RXI41xM @LaurenSchaffMD @MSKCancerCenter #PCNSL https://t.co/VPYlr9i3zi
-
-
Mashup Score: 0
By Syed Ali Abutalib, MD; Arjun Patel, PharmD, BCOP; and James Rubenstein, MD, PhD October 10, 2022 Primary central nervous system lymphoma (PCNSL) accounts for less than 1% of all non-Hodgkin lymphomas and between 3% and 4% of all brain tumors, with an age-adjusted incidence rate of four cases per million persons per year….
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
What Is the Best Induction Regimen for Newly Diagnosed PCNSL? By Syed Ali Abutalib, MD; Arjun Patel, PharmD, BCOP; and James Rubenstein, MD, PhD https://t.co/cqJzeVBtg1 #PCNSL #hematology @syed_abutalibmd
-
-
Mashup Score: 0
OUT THIS WEEK!AlloHCT not for older patients #AML @BloodJournal CART for #glioma @CD_AACRCART for #PCNSL #SCNSL meta-analysisLong-term KITE4 for ALL results @Haematologica
Source: www.getrevue.coCategories: Hematologists1, Latest HeadlinesTweet-
Issue #27” https://t.co/6qIl8ruXOM OUT THIS WEEK! AlloHCT not for older patients #AML @BloodJournal CART for #glioma @CD_AACR CART for #PCNSL #SCNSL meta-analysis Long-term KITE4 for ALL results @Haematologica
-
-
Mashup Score: 0Consolidative Autologous Stem Cell Transplantation Versus Whole Brain Radiation in PCNSL; a Nationwide Analysis - 2 year(s) ago
The best consolidation strategy after induction chemotherapy in Primary CNS Lymphoma (PCNSL) remains controversial. Our objective is to estimate the o…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
An OS advantage in favor of ASCT in #PCNSL https://t.co/pZgku1lxsp https://t.co/mhmGW05nm0
-
-
Mashup Score: 2Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation - 2 year(s) ago
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors’ suggested management approaches. The goal of this series is to help readers better understand how to apply the results of…
Source: Journal of Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
RT @EANOassociation: Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation. https://t.co/wvkdCvb4vT #btsm #pcnsl @JCO_ASCO
-
Certain genetic variants may have potential to serve as biomarkers in use of methotrexate -based regimens for treatment of primary central nervous system #lymphoma. From @HematologyAdv. https://t.co/y3awiBIRSJ #PCNSL